Related Experiment Video
Updated: Feb 1, 2026

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer
Henri Schmidt1,2, Arutha Kulasinghe3,4, Richard J N Allcock5,6
1The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove 4059, Queensland, Australia. henri.schmidt@connect.qut.edu.au.
Background:
PIK3CA pathways are the most frequently mutated oncogenic pathway in head and neck squamous cell carcinoma (HNSCC), including virally driven HNCs. PIK3CA is involved in the PI3K-PTEN-mTOR signalling pathway. PIK3CA has been implicated in HNSCC progression and PIK3CA mutations may serve as predictive biomarkers for therapy selection. Circulating tumour DNA (ctDNA) derived from necrotic and apoptotic tumour cells are thought to harbour tumour-specific genetic alterations. As such, the detection of PIK3CA alterations detected by ctDNA holds promise as a potential biomarker in HNSCC.
Methods:
Blood samples from treatment naïve HNSCC patients (n = 29) were interrogated for a commonly mutated PIK3CA hotspot mutation using low cost allele-specific Plex-PCRTM technology.
Results:
In this pilot, cross sectional study, PIK3CA E545K mutation was detected in the plasma samples of 9/29 HNSCC patients using the Plex-PCRTM technology.
Conclusion:
The results of this pilot study support the notion of using allele-specific technologies for cost-effective testing of ctDNA, and further assert the potential utility of ctDNA in HNSCC.
Insights
This pilot study detected PIK3CA E545K mutations in circulating tumor DNA (ctDNA) from head and neck squamous cell carcinoma (HNSCC) patients. Allele-specific PCR offers a promising, cost-effective method for ctDNA biomarker detection in HNSCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- PIK3CA pathway mutations are common in head and neck squamous cell carcinoma (HNSCC).
- PIK3CA mutations are implicated in HNSCC progression and may predict therapy response.
- Circulating tumor DNA (ctDNA) analysis offers a non-invasive method for detecting tumor-specific alterations.
Purpose of the Study:
- To investigate the utility of ctDNA for detecting PIK3CA mutations in HNSCC.
- To evaluate the feasibility of using low-cost allele-specific technology for ctDNA analysis.
Main Methods:
- Blood samples were collected from 29 treatment-naïve HNSCC patients.
- Low-cost, allele-specific Plex-PCR™ technology was used to detect a common PIK3CA hotspot mutation.
Main Results:
- The PIK3CA E545K mutation was detected in the plasma of 9 out of 29 (31%) HNSCC patients.
- The Plex-PCR™ technology successfully identified the target mutation in ctDNA samples.
Conclusions:
- Allele-specific technologies provide a cost-effective approach for ctDNA testing.
- ctDNA analysis holds significant potential as a biomarker for HNSCC management.
Related Concept Videos
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cancers Originate from Somatic Mutations in a Single Cell
Pilot and Numeric Relaying

